Source: Fox News
Summary
Researchers at the University of Kentucky studied an experimental medication called MW150, designed to treat mild to moderate Alzheimer’s disease, and found it may also ease alcohol withdrawal by calming brain inflammation linked to addiction and relapse. The study, published in the journal Alcohol, suggests that MW150 could mitigate neuroinflammation arising from alcohol withdrawal, which may contribute to relapse risk and long-term neurological damage in people with alcohol use disorder.
Our Reading
The advice sounds familiar. This guidance has been heard before. The recommendation enters another phase. The study provides “biological plausibility” that MW150 could mitigate neuroinflammation arising from alcohol withdrawal. The compound is already being investigated in clinical trials as a potential therapy for dementia and other neurodegenerative conditions. The research has some important caveats, including that it was conducted in cell culture and animal models.
It’s a familiar cycle: a new study emerges, suggesting a potential treatment for a complex condition, only to be followed by the need for further research and caution. As one expert noted, “no amount of alcohol consumption is good from a physical health standpoint.” Minimizing alcohol consumption remains the best strategy for staying healthy.
Author: Evan Null
